Unicycive Therapeutics Inc. (UNCY)
NASDAQ · Healthcare
Unicycive Therapeutics Inc. Income Statement 2022–2023
| Dec 2023 | Dec 2022 | |
|---|---|---|
| Revenues | ||
| Revenue | 675,000 | 951,000 |
| Gross Profit | — | — |
| Profitability | ||
| Operating Income | -20.8M | -18.1M |
| EBITDA | — | — |
| Net Income | -30.5M | -18.1M |
| Per Share Data | ||
| EPS (diluted) | — | — |
| Shares Outstanding (dil.) | 25M | 15M |
Unicycive Therapeutics Inc. Income Statement — FAQ
Unicycive Therapeutics Inc. (UNCY) income statement over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see UNCY's income statement history?
The chart and table above show Unicycive Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.